Vemurafenib acts as an aryl hydrocarbon receptor antagonist: Implications for inflammatory cutaneous adverse events.

Heike C Hawerkamp, Andreas Kislat, Peter A Gerber, Marius Pollet, Katharina M Rolfes, Anatoly A Soshilov, Michael S Denison, Afaque Ahmad Imtiyaz Momin, Stefan T. Arold, Angeliki Datsi, Stephan A Braun, Péter Oláh, Mario E Lacouture, Jean Krutmann, Thomas Haarmann-Stemmann, Bernhard Homey, Stephan Meller